Australian & New Zealand Children's Haematology/Oncology Group

1 marketed ·

Quick facts

Marketed products

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Australian & New Zealand Children's Haematology/Oncology Group

What are Australian & New Zealand Children's Haematology/Oncology Group's marketed drugs?

Top marketed products include Opdualag.

Related